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Abstract The polyomavirus enhancer binding protein 2K
(PEBP2K) is a DNA binding transcriptional regulatory protein
that binds conserved sites in the polyomavirus enhancer,
mammalian type C retroviral enhancers and T-cell receptor gene
enhancers. Binding of PEBP2K and homologous proteins to the
consensus DNA sequence TGPyGGTPy is mediated through a
protein domain known as the runt domain. Although recent
NMR studies of DNA-bound forms of the runt domain have
shown an immunoglobulin-like (Ig) fold, the identification of
residues of the protein that are involved in DNA binding has been
obscured by the low solubility of the runt domain. Constructs of
the mouse PEBP2KA1 gene were generated with N- and C-
terminal extensions beyond the runt homology region. The
construct containing residues Asp90 to Lys225 of the sequence
(PEBP2K90^225) yielded soluble protein. The residues that
participate in DNA binding were determined by comparing the
NMR spectra of free and DNA-bound PEBP2K90^225. Analysis
of the changes in the NMR spectra of the two forms of the
protein by chemical shift deviation mapping allowed the
unambiguous determination of the regions that are responsible
for specific DNA recognition by PEBP2K. Five regions in
PEBP2K90^225 that are localized at one end of the L-barrel
were found to interact with DNA, similar to the DNA binding
interactions of other Ig fold proteins.
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1. Introduction
The polyomavirus enhancer binding protein 2 (PEBP2),
also termed core binding factor (CBF) or acute myeloid leu-
kemia factor (AML), is a heteromeric DNA binding transcrip-
tional regulatory protein [1]. It consists of a T-cell-speci¢c K
subunit (PEBP2K) that mediates speci¢c DNA recognition
and a ubiquitously expressed L subunit (PEBP2L) that enhan-
ces DNA binding by the K subunit [1]. PEBP2K binds con-
served sites in mammalian type C retroviral enhancers and the
polyomavirus enhancer, contributing to the transcription of
those viruses which utilize PEBP2K for their own viral gene
expression [2,3]. PEBP2K also binds conserved sites in the
enhancers of several genes speci¢cally expressed in T cells,
including the enhancers of T-cell receptor (TCR) chain genes
K, Q, N and L, as well as the immunoglobulin W-chain gene
[2,4^6]. PEBP2K is likely to be involved in tissue-speci¢c tran-
scriptional regulation in the T-lymphocyte lineage, since it is
expressed throughout thymic T-cell development, rendering it
a participant in lymphocyte development and hematopoiesis
[7].
PEBP2K consists of a highly conserved DNA binding do-
main known as the runt domain and a variable transactiva-
tion domain at the C-terminus [6]. The runt domains of
PEBP2K and homologous proteins bind to the consensus
DNA sequence TGPyGGTPy [2,7]. Functional analysis and
deletion studies of PEBP2K cDNAs revealed that the runt
domain includes the regions involved in both DNA binding
and heterodimerization with the L subunit [1,8]. Runt domain
proteins appear to bind DNA as monomers and can bind in
the absence of their biological partner, PEBP2L [1].
In the mouse, there are three genes encoding the K subunit
of the PEBP2K protein: PEBP2KA/CBFA1/AML3, PEBP2-
KB/CBFA2/AML1 and PEBP2KC/CBFA3/AML2 [1,9,10].
Translocations at the C-terminus produce dominant-negative
fusion proteins that can bind DNA strongly but do not acti-
vate transcription normally and are involved in several types
of leukemia [11]. The AML1 (PEBP2KB) gene is encoded
on human chromosome 21 and is disrupted by the chromo-
somal translocation t(8;21)(q22;q22) associated with acute
myeloid leukemia subtype M2 [12]. Disruption by the
t(12:21)(p13;q22) translocation is found in 30% of childhood
acute lymphoblastic leukemias (pre-B-cell) [13] and
t(3;21)(q26;q22) is associated with therapy-related leukemias,
myelodysplasia or blastic crisis of chronic myelogenous leuke-
mia [14]. The biological importance of AML1 and AML3 was
further shown by targeted gene inactivations that resulted in
defects in hematopoiesis and bone formation, respectively
[15,16].
In this paper, we characterize the secondary structural ele-
ments and topology of the runt domain of murine PEBP2KA
using NMR methods. We were able to study both the free and
bound forms of the runt domain, allowing the unambiguous
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identi¢cation of the regions that interact with DNA. Struc-
tural information on the PEBP2K proteins has been limited
until recently, when two solution structures of the runt do-
main of the PEBP2KB gene (AML1, CBFA2) in the DNA-
bound form were reported [17,18]. These studies reported dif-
¢culties in the unambiguous determination of the regions that
bound DNA, due to the insolubility of the free form of the
runt domain protein. The construct that we used for our
studies was su⁄ciently soluble to allow for characterization
of the free protein at low temperatures and high salt concen-
trations. We have therefore been able to determine the regions
of the PEBP2K runt domain involved in DNA binding from
chemical shift deviation mapping combined with solution
NMR structural studies.
2. Materials and methods
2.1. Preparation of protein samples
The gene sequence of the DNA binding runt domain of PEBP2KA,
corresponding to residues 90^225 of the mouse PEBP2KA gene [1],
was ampli¢ed using PCR methods and inserted between the NdeI and
EcoRI restriction sites of the PET-21a(+) expression vector (Nova-
gen). Escherichia coli BL21(DE3) cells harboring the vector, as well as
the pUBS520 vector containing the dnaY gene (tRNAArgAGA=AGG), were
grown at 25‡C in minimal medium. Cells were induced with 1 mM
isopropyl-1-thio-L-D-galactopyranoside (IPTG) between 0.4 and 0.5
OD600. The cells were harvested after 11^12 h (15N and 15N,13C uni-
formly isotopically labeled) and 35^42 h (2H,15N,13C uniformly iso-
topically labeled) when they reached OD600 = 2. The cell pellet was
resuspended in 50 mM Tris^HCl, pH 7, 0.1 M NaCl, 1 mM phenyl-
methylsulfonyl £uoride (PMSF), 2 mM ethylene diamine tetraacetic
acid disodium salt (EDTA), 1% nonaethylene glycol octyphenyl ether
(NP-40) and 100 mM dithiothreitol (DTT). The cells were lysed after
sonication, centrifuged, and the supernatant containing the target
protein was passed through a Hi-Trap Q column equilibrated in 34
mM Tris^HCl, pH 7, 20 mM K2SO4 and 0.2% L-mercaptoethanol in
order to remove any nucleic acids bound to the target protein. The
£ow through was loaded onto a Hi-Trap SP column (Pharmacia)
equilibrated with the same bu¡er for FPLC puri¢cation. The target
protein was eluted with increasing KCl concentration. The fractions
containing the target protein were diluted and loaded onto a heparin-
Sepharose column (Pharmacia) equilibrated in 34 mM Tris^HCl, pH
7, 20 mM K2SO4, 100 mM KCl and 0.2% L-mercaptoethanol and
eluted with a KCl gradient. The eluted fractions were exchanged
and concentrated using a Centriprep-3 (Amicon) in 20 mM Tris^
HCl, pH 7, 20 mM K2SO4, 200 mM KCl and 0.2% L-mercaptoetha-
nol. The protein was kept dilute and ¢nal puri¢cation was achieved in
a Superdex-75 column (Pharmacia). Fractions were collected at the
center of the peak and purity was assessed by analytical reverse-phase
chromatography, Coomassie gradient SDS^PAGE gel electrophoresis
(Bio-Rad), electrospray and MALDI mass spectroscopy. Pure frac-
tions were concentrated to 0.2 mM and exchanged into the desired
NMR bu¡er (20 mM Tris^HCl-d8, pH 7, 20 mM K2SO4, 100 mM
KCl, 10 mM DTT and 5% D2O) using a NAP-25 column (Pharma-
cia).
2.2. DNA preparation
A DNA oligonucleotide (5P-CTCTGCGGTTAGGC-3P) and its
complementary strand, containing a high a⁄nity recognition sequence
[1,19], were obtained from Operon Technologies. Each single-stranded
oligo was puri¢ed by reverse-phase HPLC on a C18 column. Frac-
tions containing the pure oligos were lyophilized and resuspended in
200 mM KCl, pH 7 and detritylated by lowering the pH to 5.5 with
80% acetic acid. Detritylation was monitored by HPLC. After detri-
tylation was completed, the DNA solutions were neutralized to pH 7
with KOH. Strands were annealed in stoichiometric amounts and the
duplex DNA was puri¢ed via a Hi-Trap Q strong anion exchange
column equilibrated in 200 mM KCl, pH 7 and eluted with increasing
KCl concentrations. Pure fractions were combined, desalted and con-
centrated in a Centriprep-3 (Amicon) unit. The DNA duplex was
characterized from its NMR spectra.
2.3. Preparation of the protein^DNA complex
Protein in the NMR bu¡er was titrated into concentrated DNA.
Complex formation was monitored from the protein HN protons and
nitrogen NH shifts in 15N-HSQC spectra, as well as the shifts of the
DNA imino protons (HN) in NOESY spectra. Upon reaching the 1:1
ratio, the complex was diluted with NMR complex bu¡er to remove
salt that would interfere with the protein:DNA interaction and then
exchanged into 20 mM Tris^HCl, pH 6.5, 20 mM K2SO4, 10 mM
DTT, and 5% D2O and concentrated in a centrifugal concentrator
(1 kDa molecular weight cut o¡, Filtron). The concentrated protein
solution (350 WM) was transferred to an NMR tube and £ushed with
Ar or N2 gas.
2.4. NMR spectroscopy
All NMR spectra were recorded at 22‡C and 32‡C on Bruker 500
MHz AMX-II, 600 MHz DRX-Avance and 800 MHz DRX-Avance
spectrometers equipped with triple-axis shielded gradient triple-reso-
nance probes. NMR studies required 15N,15N,13C and 2H,15N,13C
isotopically labeled recombinant PEBP2K90^225. Triple-labeled
PEBP2K90^225 was 85% deuterated. NMR data processing was per-
formed using Felix97 (Molecular Simulations, San Diego, CA),
NMRPipe and NMRDraw [20]. Data were analyzed using the
NMRview software [21]. Backbone resonances of PEBP2K90^225
were assigned sequence-speci¢cally from 3D CT-HNCA, CT-
HN(CO)CA, HN(CA)CB, HN(CO)CACB, HN(CO), HN(CA)CO tri-
ple resonance data [22^25], in combination with 3D 15N-NOESY-
HSQC, 15N-TOCSY-HSQC and 15N-HSQC-NOESY-HSQC [26]
spectra. 3D 15N-edited NOESY-HSQC (dm = 125 ms) and 13C-edited
HMQC-NOESY (dm = 100 ms) spectra were recorded in order to con-
¢rm resonance assignments and also to obtain structural information
[22]. Secondary structural elements and topology were determined
from a combination of secondary chemical shift analysis and identi-
¢cation of unambiguous NOEs [22,27,28].
2.5. Chemical shift analysis
Secondary shifts were calculated using published random coil values
for HK, CK, CL and CP nuclei [29] for the PEBP2K90^225:DNA com-
plex. 1H, 15N and 13C resonances were referenced relative to 2,2-di-
methyl-2-silapentane-5-sulfonate, sodium salt (0 ppm). Appropriate
corrections to the random coil shifts were made for residues preceding
a proline residue [30] and for carbon nuclei attached to deuterium
[31].
3. Results
3.1. Design of protein and DNA constructs
The initial construct encoding mainly the runt homology
region of the murine PEBP2KA1 protein (Val95^Lys225)
proved to be highly insoluble and unsuitable for NMR stud-
ies. Several N-terminal and C-terminal extensions beyond the
runt homology region were engineered by PCR methods and
tested for solubility. One of them, which corresponds to res-
idues Asp90^Lys225 (PEBP2K90^225), proved to be moder-
ately soluble at NMR concentrations.
3.2. NMR resonance assignments of PEBP2K90^225
1H,15N-correlated NMR spectra of free PEBP2K90^225
showed signals characteristic of a folded protein plus sharp
overlapped resonances indicative of £exible regions. Data col-
lected on the free form of the protein were incomplete, with
25% of the signals missing due to broadening arising from
conformational exchange on an intermediate time scale. The
free protein was unstable at high concentrations, room tem-
perature, low pH and low salt content. Nevertheless, we were
able to make extensive backbone resonance assignments of
free PEBP2K90^225 using 3D HNCA, HN(CA)CB and 15N
NOESY spectra. Upon DNA binding, many of the resonances
that were in intermediate exchange appeared and other reso-
nances were shifted, consistent with stabilization or structural
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rearrangement of the regions involved in DNA binding (Fig.
1).
3.3. NMR resonance assignments of PEBP2K90^225 bound to
a DNA duplex
The 1H,15N-HSQC spectrum of PEBP2K90^225 is well dis-
persed when it is complexed to DNA, indicating a unique
folded conformation. Almost complete backbone resonance
assignments were made. No amide proton NMR signals
were assigned for backbone amide protons of residues N-ter-
minal Met, Asp90, Arg123^Cys124, Gly184^Lys187, His206^
Ile209 and Thr212^Gly216; these signals were broadened due
to intermediate exchange. For the remaining residues, sequen-
tial connectivities were observed in the 15N-edited NOESY
data and the triple resonance data. Although chemical shift
dispersion of the majority of the backbone HN protons is
good, signal degeneracies were observed for many of the
loop regions as well as some of the extended regions. Some
of the signals a¡ected upon binding to DNA were in confor-
mational exchange and too broad to be fully characterized. At
low temperature, the complex appeared to be unstable, and
resonances of the free form of the protein and the DNA
duplex dominated the spectrum, with the signals of the com-
plexed form being extremely broad. Data were collected at
two temperatures, 22‡C and 32‡C, in order to assign resonan-
ces that were in the NMR intermediate time scale and over-
lapped. Data could not be collected at higher temperatures
due to rapid precipitation of the sample.
3.4. Secondary structure determination
Elements of secondary structure were identi¢ed on the basis
of the secondary chemical shifts of the HK, CK, CL, CP nuclei
(Fig. 2). This information combined with the results from the
15N-NOESY-HSQC, 15N-HSQC-NOESY-HSQC and 13C-
HMQC-NOESY spectra allowed determination of the topol-
ogy of PEBP2K90^225. The secondary chemical shift of a
particular nucleus is de¢ned as the di¡erence between the
observed chemical shift and its random coil value. Theoretical
calculations and empirical correlations have established that
the secondary chemical shifts of certain backbone nuclei are
largely determined by the local (P,i) dihedral angles. This
approach has been found to be extremely useful for identify-
ing secondary structural elements of folded proteins and pep-
tides [29]. The secondary shifts for the HK, CK, CL, CP of the
assigned signals in PEBP2K90^225, together with NOE infor-
mation from the 15N-edited NOESY, allowed the identi-
¢cation of L-strands, loops and turns for the secondary struc-
ture of PEBP2K90^225 (Fig. 2). From the NOE data, it
was possible to de¢ne the topology of the L-sheets in
the core. The runt domain in PEBP2K90^225 consists of at
least 12 L-strands that we de¢ne as: L1(Val95^Ile98),
L2(Leu105^Ser110), L3(Asn112^Leu118), L4(Lys126^Leu128),
L5(Phe132^Ala136), L6(Thr144^Gly151), L7(Ser157^Arg161),
L8(Ser164^Lys168), L9(Val171^Phe174), L10(Arg178^Gly181),
L11(Lys187^Val195), L12(Gln201^Tyr205). Of these strands,
eight are arranged in a classical Greek key L-barrel [32]
(Fig. 3). There are three L-hairpin connections, two tight
turns, T1(Ser110^Asn112) and T2(Lys168^Gln170) and a lon-
ger connection T3(Phe196^Pro200) containing two Pro resi-
Fig. 1. 1H,15N-HSQC spectra recorded at 800 MHz under condi-
tions described in the text of (a) free PEBP2K90^225 and (b)
PEBP2K90^225 bound to DNA. Some of the resonances that are
signi¢cantly shifted upon complexation with DNA are labeled. Argi-
nine side chain resonances are encircled.
Fig. 2. Secondary chemical shifts plotted for (a) HK, (b) CK, (c) CL
and (d) CP nuclei of the PEBP2K90^225:DNA complex. The car-
toon on top of the ¢gure depicts the location of the L-strands in
the runt domain.
FEBS 23437 16-3-00 Cyaan Magenta Geel Zwart
G.C. Pe¤rez-Alvarado et al./FEBS Letters 470 (2000) 125^130 127
dues (Fig. 3). The topology of the Greek key motif was de-
termined from the NOEs across the L-strands, as well as the
NOEs that de¢ned the tight L-turns. A summary of the NOE
connectivities that determine the topology of the L-strands of
PEBP2K90^225 is given in Fig. 3.
3.5. Mapping of residues involved in DNA binding
The regions in PEBP2K90^225 that are in£uenced by DNA
binding were determined from changes in the backbone amide
proton HN and 15N chemical shifts upon binding to DNA
(Fig. 4). The deviation in the chemical shift upon binding
was evaluated using the formula: vav = k[(vH)2+(vN/5)2],
where chemical shift changes between free and bound forms
of the protein are represented by vH for the amide protons
and vN for the amide nitrogens [33]. The chemical shifts of the
backbone amide resonances remain unchanged for a large
portion of the residues in PEBP2K90^225. Chemical shift dif-
ferences above a threshold value (vNs 0.07 ppm) are apparent
for about 40% of the resonances, which correspond to resi-
dues in ¢ve main regions within PEBP2K90^225. Shifts in
these regions are consistent with mutagenesis data in which
DNA binding is a¡ected. The major changes in chemical shift
correspond to residues Arg92, Val95^Glu96, Ile98^Ala99,
His101, Glu104, Cys115, Val117^Leu118, His121^Trp122,
Asn125^Lys126, Ala131^Val134, Ala150^Asn152, Tyr156,
Ala158, Arg173^Phe174, Asp176^Leu177, Arg182, Phe189,
Val211, Arg220^Arg223 and Lys225. Resonances of Ser120,
Thr127, Leu128, Glu154^Asn155, Ser157, Glu159, Arg161,
Arg178, Val180^Gly181, Ser183, Ser188, Thr190^Leu191
and Lys210 (marked with * in Fig. 4) were not present in
the data of free PEBP2K90^225 and appeared upon complex
formation with DNA.
4. Discussion
The L-strand topology of PEBP2K90^225 contains a Greek
key motif formed by strands L3, L5, L9, L8 and L6. The top-
ology of the strands resembles that of Cu,Zn-superoxide dis-
mutase subunit (SOD) [34] and the immunoglobulin s-type
and c-type chains [35]. Immunoglobulin-like folds are present
in a diverse family of structures with no shared sequence
Fig. 3. Summary of some of the backbone NOE connectivities that de¢ne the topology of the L-sheets in PEBP2K90^225. Residues surrounded
by rectangles indicate slow HN exchange.
Fig. 4. Chemical shift deviations between free PEBP2K90^225 and
PEBP2K90^225 bound to 5P-CTCTGCGGTTAGGC-3P plotted by
residue. The dashed line in the graph corresponds to the threshold
deviation (0.07 ppm). The asterisks indicate residues for which NH
cross-peaks were not observed in the free form of the protein. The
cartoon on top of the ¢gure depicts the secondary structural ele-
ments in the DNA binding domain. No values are reported for resi-
dues 102, 111, 119, 129, 141, 199, 200, 216 and 219, which are pro-
lines.
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homology or function. The runt homology region does not
present primary sequence homology with any other proteins
out of the immediate runt family. The topology of
PEBP2K90^225 resembles mostly that of Cu,Zn-SOD as de-
¢ned by its hydrogen bond pattern deduced from the NOE
data (Fig. 5) [36]. The reported structures of the runt domain
of CBFA2 or AML1 de¢ned a L-sheet topology similar to
that of the immunoglobulin s-type fold composed of seven
L-strands [17,18]. From our data, we de¢ned a L-sheet top-
ology composed of eight strands, which similarly to SOD are
within hydrogen bonding distance of each other (Fig. 5).
The resonances of PEBP2K90^225 that are perturbed by
DNA binding are mainly from residues in loops at one end
of the molecule; resonances in the core L-sheets are relatively
una¡ected by DNA binding (Fig. 4). The chemical shift
changes probably re£ect direct contacts with the DNA or
local conformational changes associated with DNA interac-
tions. The largest chemical shift perturbations occur in ¢ve
regions, as shown in Fig. 5. It is notable that mutations
known to modulate DNA binding are all localized in the
regions implicated in DNA contact by the chemical shift per-
turbations. Region I at the N-terminus (residues Val95^
Val106) and region V at the C-terminus (residues Arg220^
Lys225) (Fig. 5) do not form part of the core, but are still
within the runt homology region. Interestingly, these regions
are sensitive in vivo to mutations and deletions that modulate
binding of PEBP2K to DNA [37^39].
Region II (residues Cys115^Val134) shows major chemical
shift deviations upon DNA binding. Site-directed mutagenesis
or oxidation of the highly conserved Cys115 is detrimental to
DNA binding activity [40,41]. Another cysteine within this
region, Cys124, is not fully conserved among the di¡erent
runt domain sequences and is replaced by a Ser in the Dro-
sophila gene products. The Cys124Ser mutation enhances
DNA binding, while the Cys124Asp substitution is deleterious
[41]. Werner and coworkers observed intermolecular NOEs to
DNA from Val117 and Arg123, but not from any other res-
idues, con¢rming that region II makes direct contact with the
DNA and supporting our chemical shift mapping experi-
ments. In region III (Ala150^Ala163), the Ala150Thr muta-
tion diminishes DNA binding activity [42]. Mutations within
region IV (residues Arg173^Thr192) have also proven to be
detrimental to DNA binding (residues Arg173, Arg178,
Ser183, Lys187, Phe189) [37,38,43,44].
The identi¢cation of the ¢ve regions in PEBP2K90^225 that
participate in DNA recognition provides insights into the
structural basis by which mutations in these regions a¡ect
DNA binding. All of these regions are localized at one end
of the L-barrel in PEBP2K, as in other Ig folds that interact
with DNA (the N-terminal domain of the Rel homology re-
gion of NF-UB, the core domain of the p53 tumor suppressor
and STAT-1 [45^47]). It has been suggested that the runt
domain interacts with DNA at both ends of the L-barrel
[18], but our results do not support these suggestions.
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